The upcoming webinar is Tuesday, December 11, 2018 from 9:30 a.m. - 10 a.m.
To attend, use the login information provided at the bottom of the invitation. This is a short form webinar. Presentations are approximately 10 minutes in length for each individual technology. There are opportunities to ask questions between presentations, as well as through the WebEx chat feature after you login.
On Tap/Programming Schedule:
9:30 a.m. - 9:45 a.m. First Presentation
Technology #1: The University of Missouri-Columbia will present broad-spectrum antiviral therapeutics to treat a broad spectrum of clinically relevant viral infections. Data in mice demonstrate significant rescue from lethal doses of Influenza A. In vitro data extend application to other viruses.
9:45 a.m. -10 a.m. Second Presentation
Technology #2: The University of Missouri-Columbia will present a targeted and programmable delivery of peptide inhibitors to treat cancer. Data in cells demonstrate efficacy in hematological (lymphoma/leukemia), skin, breast, prostate, and lung cancers. Alternate potential applications include autoimmunity and viral infection.
Post webinar, Technology Snapshots email will be sent to the Whiteboard2Boardroom network - highlighting the technologies presented.
If you or someone in your network would like to connect with the University of Missouri in regards to the technology presented, please do not hesitate to contact us. Email Jim Baxendale, email@example.com
As always, we appreciate your support of our efforts to connect university, hospital and corporate innovations with talent to move them into the marketplace, and welcome your feedback.
Join the meeting: https://umkc.webex.com/umkc/onstage/g.php?MTID=e013d8cee75f492aa6c952f5c6fd01fcf
Dial in by phone:
Conference ID: 927 015 939